Tayanes, Gemma .
HRN: 28-80-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CEFUROXIME 1.5GM (VIAL)
04/07/2026
04/14/2026
IV
1.5
Ptor
Pelvic Lap
Checking Initial Appropriateness
04/07/2026
CLINDAMYCIN 300MG (CAP)
04/07/2026
04/14/2026
PO
1 Tab
BID
S/P Pelvic Lap
Checking Initial Appropriateness
04/07/2026
DOXYCYCLINE 100MG (CAP)
04/07/2026
04/14/2026
PO
1 Tab
BID
S/P Pelvic Lap
Checking Initial Appropriateness
04/07/2026
MUPIROCIN 2%, 15G (TUBE)
04/07/2026
04/14/2026
TOPICAL
Pea Sized
OD
S/P Pelvic Lap
Checking Initial Appropriateness
04/07/2026
MUPIROCIN 2%, 15G (TUBE)
04/07/2026
04/14/2026
TOPICAL
Pea Sized
OD
S/P Pelvic Lap
Checking Initial Appropriateness